Drug intelligence / Profile preview

Huangjin Shuangshen Jiawei

Development stage: Unknown
Lead developer: China Resources Sanjiu Medical & Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Huangjin Shuangshen Jiawei (黄金双参加味颗粒) is a traditional Chinese medicine (TCM) formulation in granule form. It is used primarily within the context of TCM clinical practice and research. The specific composition typically includes a combination of herbal ingredients, but the exact formula and mechanism are not detailed in available sources. Its use appears to be associated with academic or institutional procurement for research or educational purposes at Zhejiang Chinese Medical University[1][2]. There is no evidence it is an internationally recognized pharmaceutical product or that it has undergone Western-style clinical trials.

Brand names: Huangjin Shuangshen Jiawei黄金双参加味颗粒
Other names: 黄金双参加味颗粒Huangjin Shuangshen Jiawei Keli

Beyond the preview

Go deeper on Huangjin Shuangshen Jiawei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangjin Shuangshen Jiawei.

Explore the full profile